Primary Biliary Cholangitis Treatment Market: Overview Global primary biliary cholangitis treatment market is witnessing significant changes due to recent approval of UDCA by several regulatory authorities across the globe. In May 2016, the FDA approved obeticholic acid in combination with UDCA for primary biliary cholangitis (PBC) in adult patients with an inadequate response to UDCA. U.K’s NICE …
Continue reading “Primary Biliary Cholangitis Treatment Market Size, Country-wise Insights to 2027”